195 related articles for article (PubMed ID: 27181204)
21. Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
Blanco-Gómez A; Hontecillas-Prieto L; Corchado-Cobos R; García-Sancha N; Salvador N; Castellanos-Martín A; Sáez-Freire MDM; Mendiburu-Eliçabe M; Alonso-López D; De Las Rivas J; Lorente M; García-Casas A; Del Carmen S; Abad-Hernández MDM; Cruz-Hernández JJ; Rodríguez-Sánchez CA; Claros-Ampuero J; García-Cenador B; García-Criado J; Orimo A; Gridley T; Pérez-Losada J; Castillo-Lluva S
Cancer Res; 2020 Dec; 80(23):5216-5230. PubMed ID: 33023950
[TBL] [Abstract][Full Text] [Related]
22. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
[TBL] [Abstract][Full Text] [Related]
23. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.
Jin K; Park S; Teo WW; Korangath P; Cho SS; Yoshida T; Győrffy B; Goswami CP; Nakshatri H; Cruz LA; Zhou W; Ji H; Su Y; Ekram M; Wu Z; Zhu T; Polyak K; Sukumar S
Cancer Discov; 2015 Sep; 5(9):944-59. PubMed ID: 26180042
[TBL] [Abstract][Full Text] [Related]
24. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
25. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
26. PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.
Zhou S; Si J; Liu T; DeWille JW
J Biol Chem; 2008 Jul; 283(29):20137-48. PubMed ID: 18477566
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
28. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
[TBL] [Abstract][Full Text] [Related]
29. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
31. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
32. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
[TBL] [Abstract][Full Text] [Related]
33. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
34. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells.
Zhang Y; Liu T; Yan P; Huang T; Dewille J
BMC Mol Biol; 2008 Oct; 9():83. PubMed ID: 18828910
[TBL] [Abstract][Full Text] [Related]
36. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
37. Lapatinib restores hormone sensitivity with differential effects on estrogen receptor signaling in cell models of human epidermal growth factor receptor 2-negative breast cancer with acquired endocrine resistance.
Leary AF; Drury S; Detre S; Pancholi S; Lykkesfeldt AE; Martin LA; Dowsett M; Johnston SR
Clin Cancer Res; 2010 Mar; 16(5):1486-97. PubMed ID: 20179226
[TBL] [Abstract][Full Text] [Related]
38. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
39. The many faces of C/EBPδ and their relevance for inflammation and cancer.
Balamurugan K; Sterneck E
Int J Biol Sci; 2013; 9(9):917-33. PubMed ID: 24155666
[TBL] [Abstract][Full Text] [Related]
40. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]